Daily Coverage San Francisco 2016


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

  • Bookmark
  • Share this Video


by David Eichenbaum, MD

David Eichenbaum, MD, reviews data from the HARBOR study, paying particular attention to patients with pigment epithelial detachments (PEDs). Dr. Eichenbaum explains that the study data point to a relationship between ranibizumab therapy and visual improvement in patients with PEDs in HARBOR, and that a significant number of patients saw PED resolution after ranibizumab therapy. However, as Dr. Eichenbaum points out, some of the HARBOR data raise as many questions as they answer.

Comments (0)